Literature DB >> 15849066

Systemic markers of the redox balance in chronic obstructive pulmonary disease.

M C Santos1, A L Oliveira, A M Viegas-Crespo, L Vicente, A Barreiros, P Monteiro, T Pinheiro, A Bugalho De Almeida.   

Abstract

Chronic obstructive pulmonary disease (COPD) is highly prevalent and its pathogenesis is still not completely clarified. Clinically stable patients (n=21) and healthy subjects (n=24) were studied for blood markers of oxidative injury and antioxidant status. The plasma concentration of protein carbonyls was significantly increased in COPD patients, both ex-smokers (0.76 +/- 0.28 nmol mg(-1)) and smokers (0.99 +/- 020 nmol mg(-1)) versus controls (0.49 +/- 0.14 nmol mg(-1)) . The concentration of total thiols was slightly enhanced in plasma of the COPD patients (ex-smokers 492 +/- 23 micromol 1(-1) and smokers 505 +/- 36 micromol 1(-1) versus controls 450 +/- 67 micromol 1(-1); p < 0.05). The activity of the antioxidant enzyme superoxide dismutase was increased in erythrocytes (activity in U g(-1) haemoglobin; ex-smokers 4460 +/- 763 and smokers 4114+/- 1060 versus 3015 +/- 851 in controls; p > 0.01), while glutathione peroxidase activity was decreased in total blood (activity in U g(-1) haemoglobin: ex-smokers 27 +/- 9 and smokers 23 +/- 9 versus 47 +/- 25; p < 0.01). Lower levels of selenium in plasma were also found for COPD patients (concentration in mg 1(-1): ex-smokers 0.030 +/- 0.019 and smokers 0.032 +/- 0.024 versus 0.058 +/- 0.023 in controls; p < 0.01), being more evident in those with very low levels of arterial oxygen pressure. In addition, the levels of potassium and rubidium were increased in blood cells of the patient group. All these changes might reflect oxidant damage and an altered electrolytic homeostasis, and can be interpreted as markers of COPD rather than as indicators of smoking habits.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15849066     DOI: 10.1080/13547500400024768

Source DB:  PubMed          Journal:  Biomarkers        ISSN: 1354-750X            Impact factor:   2.658


  20 in total

1.  Oxidative stress in patients with COPD and pulmonary hypertension.

Authors:  Pavol Joppa; Darina Petrásová; Branislav Stancák; Zuzana Dorková; Ruzena Tkácová
Journal:  Wien Klin Wochenschr       Date:  2007       Impact factor: 1.704

2.  Plasma cysteine/cystine and glutathione/glutathione disulfide redox potentials in HIV and COPD patients.

Authors:  Walter H Watson; Jeffrey D Ritzenthaler; Paula Peyrani; Timothy L Wiemken; Stephen Furmanek; Andrea M Reyes Vega; Tom J Burke; Yuxuan Zheng; Julio A Ramirez; Jesse Roman
Journal:  Free Radic Biol Med       Date:  2019-07-29       Impact factor: 7.376

Review 3.  Novel drug delivery systems targeting oxidative stress in chronic obstructive pulmonary disease: a review.

Authors:  You Xu; Hongmei Liu; Lei Song
Journal:  J Nanobiotechnology       Date:  2020-10-19       Impact factor: 10.435

4.  Targeting c-Src Reverses Accelerated GPX-1 mRNA Decay in Chronic Obstructive Pulmonary Disease Airway Epithelial Cells.

Authors:  Abdoulaye J Dabo; Wendy Ezegbunam; Anne E Wyman; Jane Moon; Christopher Railwah; Alnardo Lora; Susan M Majka; Patrick Geraghty; Robert F Foronjy
Journal:  Am J Respir Cell Mol Biol       Date:  2020-05       Impact factor: 6.914

5.  Antioxidants and Chronic Obstructive Pulmonary Disease.

Authors:  Félix-Antoine Vézina; André M Cantin
Journal:  Chronic Obstr Pulm Dis       Date:  2018-10-08

6.  Selenium deficiency alters epithelial cell morphology and responses to influenza.

Authors:  I Jaspers; W Zhang; L E Brighton; J L Carson; M Styblo; M A Beck
Journal:  Free Radic Biol Med       Date:  2007-03-24       Impact factor: 7.376

7.  Surrogate scale for evaluating respiratory function based on complete blood count parameters.

Authors:  Yang Guang; Zhou Jie; Dong Feng; Liu Hui
Journal:  J Clin Lab Anal       Date:  2018-01-15       Impact factor: 2.352

Review 8.  Glutathione peroxidase-1 as a novel therapeutic target for COPD.

Authors:  Ross Vlahos; Steven Bozinovski
Journal:  Redox Rep       Date:  2013       Impact factor: 4.412

9.  Ebselen reduces cigarette smoke-induced endothelial dysfunction in mice.

Authors:  Kurt Brassington; Stanley M H Chan; Huei Jiunn Seow; Aleksandar Dobric; Steven Bozinovski; Stavros Selemidis; Ross Vlahos
Journal:  Br J Pharmacol       Date:  2021-02-27       Impact factor: 8.739

10.  Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases.

Authors:  Douglas B Kell
Journal:  BMC Med Genomics       Date:  2009-01-08       Impact factor: 3.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.